184 related articles for article (PubMed ID: 19709134)
1. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
Rauchenzauner M; Griesmacher A; Tatarczyk T; Haberlandt E; Strasak A; Zimmerhackl LB; Falkensammer G; Luef G; Högler W
Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134
[TBL] [Abstract][Full Text] [Related]
2. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
5. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
6. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
[TBL] [Abstract][Full Text] [Related]
7. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.
Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K
Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963
[TBL] [Abstract][Full Text] [Related]
8. The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy.
Cansu A; Yesilkaya E; Serdaroglu A; Camurdan O; Hirfanoglu TL; Karaoglu A; Bideci A; Cinaz P
Endocr Res; 2012; 37(4):163-74. PubMed ID: 22630163
[TBL] [Abstract][Full Text] [Related]
9. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Lin CM; Fan HC; Chao TY; Chu DM; Lai CC; Wang CC; Chen SJ
BMC Pediatr; 2016 May; 16():61. PubMed ID: 27142370
[TBL] [Abstract][Full Text] [Related]
10. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Elwakkad AS; El Elshamy KA; Sibaii H
Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
[TBL] [Abstract][Full Text] [Related]
11. Effect of carbamazepine and valproate on bone mineral density.
Ecevit C; Aydoğan A; Kavakli T; Altinöz S
Pediatr Neurol; 2004 Oct; 31(4):279-82. PubMed ID: 15464641
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
13. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study.
Bauer S; Hofbauer LC; Rauner M; Strzelczyk A; Kellinghaus C; Hallmeyer-Elgner S; Oertel WH; Rosenow F
Epilepsy Res; 2013 Oct; 106(3):417-22. PubMed ID: 23916144
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
Kim JY; Lee HW
Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
[TBL] [Abstract][Full Text] [Related]
15. Effect of antiepileptic drug comedication on lamotrigine clearance.
Weintraub D; Buchsbaum R; Resor SR; Hirsch LJ
Arch Neurol; 2005 Sep; 62(9):1432-6. PubMed ID: 16157751
[TBL] [Abstract][Full Text] [Related]
16. Weight gain in children on oxcarbazepine monotherapy.
Garoufi A; Vartzelis G; Tsentidis C; Attilakos A; Koemtzidou E; Kossiva L; Katsarou E; Soldatou A
Epilepsy Res; 2016 May; 122():110-3. PubMed ID: 27010568
[TBL] [Abstract][Full Text] [Related]
17. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
18. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
19. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drugs and bone metabolism in children: data from 128 patients.
Borusiak P; Langer T; Heruth M; Karenfort M; Bettendorf U; Jenke AC
J Child Neurol; 2013 Feb; 28(2):176-83. PubMed ID: 22550090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
